GlassScriptPhysician profile
Hossein Sadeghi
NPI 1063423028
$2,746.32
in general payments reported to CMS, 2019-2025
25 companies · $560 in 2025
The $560 reported for 2025 was more than what 80% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $375 · 2021: $46.10 · 2022: $49.21 · 2023: $352 · 2024: $707 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,424 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.40 |
| Education | $194.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $735.38 | 2019-2020 | |
| Coloplast Corp | $554.95 | 2024-2025 | |
| Mylan Specialty L.P. | $288.35 | 2023-2024 | Tobi Podhaler |
| Viatris Specialty LLC | $174.72 | 2025 | Tobi Podhaler |
| Astrazeneca Pharmaceuticals LP | $123.80 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $97.66 | 2019-2025 | |
| Inspire Medical Systems, INC. | $88.28 | 2023 | Inspire |
| Baxter Healthcare | $86.66 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Allergan, INC. | $83.41 | 2019 | |
| Nestle Healthcare Nutrition INC. | $75.41 | 2021-2022 | |
| Icu Medical INC | $60.86 | 2024 | Acapella |
| Genentech USA, INC. | $59.37 | 2019 | |
| Chiesi USA, INC. | $43.11 | 2019 | |
| Alcresta Therapeutics, INC. | $38.93 | 2022-2023 | Relizorb |
| Novartis Pharmaceuticals Corporation | $38.09 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $35.20 | 2024 | Nucala |
| Abbvie INC. | $32.01 | 2019 | |
| Genzyme Corporation | $27.03 | 2024 | |
| Electromed, INC. | $21.20 | 2025 | Smartvest |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Vapotherm INC | $17.29 | 2025 | Vapotherm |
| 3b Medical, INC. | $16.20 | 2024 | Luna |
| Amgen INC. | $16.11 | 2024 | Tezspire |
| Vivus LLC | $14.92 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hossein Sadeghi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.